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Abstract Patients with transient monocular blindness
(TMB) can present with many different symptoms, and
diagnosis is usually based on the history alone. In this
study, we assessed the risk of vascular complications
according to different characteristics of TMB. We
prospectively studied 341 consecutive patients with TMB.
All patients were interviewed by a single investigator with
a standardized questionnaire; reported symptoms were
classified into predefined categories. We performed Cox
regression analyses with adjustment for baseline vascular
risk factors. During a mean follow-up of 4.0 years, the
primary outcome event of vascular death, stroke, myocar-
dial infarction, or retinal infarction occurred in 60 patients
(annual incidence 4.4 %, 95 % confidence interval (CI)
3.4–5.7). An ipsilateral ischemic stroke occurred in 14
patients; an ipsilateral retinal infarct in six. Characteristics
of TMB independently associated with subsequent vascular
events were: involvement of only the peripheral part of the
visual field (hazard ratio (HR) 6.5, 95 % CI 3.0–14.1),
constricting onset of loss of vision (HR 3.5, 95 % CI
1.0–12.1), downward onset of loss of vision (HR 1.9, 95 %
CI 1.0–3.5), upward resolution of loss of vision (HR 2.0,
95 % CI 1.0–4.0), and the occurrence of more than three
attacks (HR 1.7, 95 % CI 1.0–2.9). We could not identify
characteristics of TMB that predicted a low risk of vascular
complications. In conclusion, careful recording the features
of the attack in patients with TMB can provide important
information about the risk of future vascular events.
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Introduction
Transient monocular blindness (TMB) or amaurosis fugax
[1] is usually attributed to temporary ischemia of the retina,
or part of it. Therefore, these episodes are considered
transient ischemic attacks (TIAs) in the territory of the
ipsilateral internal carotid artery (ICA) [2]. In general,
patients with TMB associated with atheromatous disease in
the carotid artery have an average 1 year risk of recurrent
stroke of 2 % [3, 4], but in patients with severe ICA
stenosis the risk of ipsilateral stroke is up to 16 % after
3 years [5]. Overall, the risk is two to three times lower
than in patients with cerebral TIA [5, 6].
The diagnosis of TMB may be difficult, because the
history is the only source of information while the range of
visual symptoms is almost unlimited [7, 8]. Consequently,
management can be difficult as well; because it is unknown
which patterns are most relevant with respect to future
vascular complications. Therefore, it is often challenging to
distinguish between TMB with a high risk versus low risk.
Electronic supplementary material The online version of this
article (doi:10.1007/s00415-016-8189-x) contains supplementary
material, which is available to authorized users.
& Eline J. Volkers
E.J.Volkers@umcutrecht.nl
1 University Department of Neurology and Neurosurgery,
Brain Center Rudolf Magnus, University Medical Center
Utrecht, Utrecht, The Netherlands
2 Julius Center for Health Sciences and Primary Care,
University Medical Center Utrecht, Utrecht, The Netherlands
3 Department of Neurology, Diakonessenhuis, Utrecht,
The Netherlands
4 Department of Neurology, Erasmus Medical Center,
Rotterdam, The Netherlands
123
J Neurol (2016) 263:1771–1777
DOI 10.1007/s00415-016-8189-x
Earlier research on the predictive value of history
characteristics of TMB focused on the relationship between
visual symptoms and presence of ipsilateral carotid
atherosclerotic disease or other sources of emboli [8–10].
For the current study, we hypothesized that specific
patterns of transient monocular loss of vision may carry a
different prognosis, which might guide clinicians in dif-




Between September 1992 and March 1996, we prospec-
tively included 341 consecutive patients from 18 centers.
Patients were required to have experienced sudden, tran-
sient loss of vision in one eye in the previous 6 months; the
attacks did not last longer than 24 h and were not caused by
known ophthalmological disease.
This study was approved by the central research ethics
committee of the University Medical Center Utrecht, The
Netherlands; all patients gave written informed consent to
participate.
History characteristics
All patients were interviewed about the details of the attack
by one and the same investigator (RCJMD). The median
interval between the last attack and the interview was
8 weeks. This detailed history was guided by a standard-
ized questionnaire (Supplementary Table 1). If the patient
did not spontaneously mention a characteristic of a given
category, the possibilities in that category were read out by
the investigator, after which the patient could answer ‘yes’,
‘no’, or ‘I do not know’. If a symptom not listed in Sup-
plementary Table 1 was mentioned by the patient, the
characteristic was recorded in the patient’s own words;
afterwards two of us (RCJMD, LJK) classified them as
belonging to one of the predefined categories, without
having access to the results of ancillary investigations.
Disagreements on this classification were resolved by dis-
cussion. To exclude relevant ophthalmological disease we
referred all patients for consultation to an ophthalmologist.
Baseline characteristics
The following patient characteristics were recorded: age,
sex, current smoking, diabetes mellitus, hypercholes-
terolemia, atrial fibrillation, coronary artery disease (his-
tory of angina or myocardial infarction), hypertension,
intermittent claudication, previous TIA or stroke, migraine,
or glaucoma. The overall handicap of patients was graded
with the modified Rankin scale [11, 12]. Blood tests were
performed for total cholesterol and an electrocardiogram
was obtained. Patients underwent duplex ultrasonography
of the carotid arteries at study entry. Atherosclerotic lesions
of the ipsilateral ICA were graded according to peak sys-
tolic velocities on duplex ultrasonography and categorized
into the following categories: normal diameter, stenosis
between 1 and 69 %, stenosis between 70 and 99 %, and
occlusion.
Follow-up
We followed all patients for a period of at least 3 years,
with six monthly intervals. The follow-up contact consisted
of a hospital visit, or it was performed through a stan-
dardized telephone interview by the study coordinator.
Each time we ascertained the occurrence of possible out-
come events, the continuation of the attacks, or other
manifestations of vascular disease.
Outcome events
The primary outcome event was the composite of death
from all vascular causes, non-fatal stroke, non-fatal
myocardial infarction, or retinal infarction, whichever
happened first. The secondary outcome event was the
occurrence of ipsilateral ischemic stroke or ipsilateral
retinal infarction.
The definition of death from vascular causes included
sudden death, cardiac death, or death from stroke. For the
diagnosis of non-fatal stroke, sudden and focal neurologi-
cal deficits persisting for more than 24 h had to correspond
with a new infarct or hemorrhage on a repeated CT scan, or
had to cause a permanent increase in handicap of at least
one grade on the modified Rankin scale [11, 12].
Myocardial infarction had to be documented by at least two
of the following characteristics: a history of chest dis-
comfort, specific cardiac enzyme levels more than twice
the upper limit of normal, or development of Q waves on
the standard 12-lead electrocardiogram. Retinal infarction
had to be documented by a history of persistent loss of
vision in one eye and by typical changes on funduscopy.
All outcome events were independently classified by three
members of the auditing committee for outcome events.
The committee members were unaware of the symptoms
reported by the patient at baseline and the results from
ancillary investigations.
Statistical analysis
We estimated that during a 3 years inclusion period 210
patients could be entered into the study and that each
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patient could be followed for at least 3 years. Thus, 945
patient follow-up years could be obtained. In the Dutch
TIA trial, conducted at the end of the 1980s, the rate of
vascular events of patients with TMB was 3 % per year
(Dutch TIA trial; unpublished data). On the assumption a
history characteristic has a prevalence of 50 %, a risk ratio
of 3 would have a 95 % confidence interval (CI) of 1.3–7.0.
We related features of TMB with the occurrence of
outcome events in terms of hazard ratios (HRs), with cor-
responding 95 % CIs by means of Cox proportional haz-
ards modeling. For those features of TMB that showed a
statistically significant association with outcome in uni-
variable analysis, we additionally performed adjusted
analyses. In consecutive bivariable analyses we assessed
which other patient characteristics including age, sex, and
presence of vascular risk factors changed the crude hazard
ratio importantly. These characteristics were taken into
account in multivariable analysis to obtain fully adjusted
estimates. The maximum number of characteristics that
could be adjusted for was limited by the total number of
outcome events; one variable for every ten outcome events.
We made Kaplan–Meier curves to graphically assess the
cumulative risks of the features of the history that showed a
statistically significant relationship with the primary out-
come event.
Results
The mean age of the 341 patients was 61.9 ± 12.3 years;
57 % were male (Table 1). Mean follow-up was 4.0 years
(median 4.1), resulting in 1364 patient years. Two patients
were lost to follow-up after event-free periods of 3.7 and
1.7 years, respectively. Ophthalmological examination was
Table 1 Baseline
characteristics
Variable Total study population (n = 341)
Age, years (mean, SD) 61.9 (12.3)
Male sex 196 (57 %)
History of
Diabetes mellitus 22 (7 %)
Hypertension 150 (44 %)
Intermittent claudication 67 (20 %)
Myocardial infarction 52 (15 %)
Atrial fibrillation 12 (4 %)
Angina pectoris 78 (23 %)
TIA or stroke 106 (31 %)
Migrainea 42 (13 %)
Smoking 127 (37 %)
Total cholesterol C6.0 mmol/L 199 (58 %)
Medication use at baseline
Antithrombotic
Antiplatelet 231 (68 %)
Anticoagulant 60 (18 %)
Both antiplatelet and anticoagulant 14 (4 %)
Antihypertensive 110 (32 %)
Lipid-lowering 22 (7 %)
Antidiabetic 10 (3 %)
Degree of stenosis of ipsilateral ICAa, b
No stenosis 158 (47 %)
Mild or moderate stenosis (1–69 %) 33 (10 %)
Severe stenosis (C70–99 %) 100 (30 %)
Occlusion 45 (13 %)
CEA performed on ipsilateral side during study 81 (24 %)
Delay between first event and interview, days (median, IQR) 56 (17.5–107.0)
a Unknown in five patients
b According to duplex ultrasonography performed at baseline
SD standard deviation, TIA transient ischemic attack, ICA internal carotid artery, CEA carotid
endarterectomy, IQR interquartile range
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performed in 299 (88 %) patients; in the other 42 patients it
was not possible for logistic reasons. Funduscopy of the
symptomatic eye showed permanent arterial branch occlu-
sion in four patients and possible symptomatic retinal emboli
in eight patients; the emboli were judged to consist of
cholesterol in six patients and of platelets or calcified
material in two other patients. A chronic ischemic syndrome
of the eye [13] was diagnosed in five patients. Increased
ocular pressure was found to coexist in three patients, one of
whom had a concurrent ischemic syndrome of the eye.
Baseline characteristics are summarized in Table 1. In
296 (87 %) patients at least one of the following vascular
risk factors was present: diabetes mellitus, hypertension,
smoking, or total cholesterol of C6.0 mmol/L. The pro-
portion of patients who used antithrombotic medication at
baseline was comparable with the proportion of patients
who used antithrombotic medication during follow-up.
The primary (composite) outcome event occurred in 60
patients (annual incidence 4.4 %, 95 % CI 3.4–5.7 %).
Ipsilateral ischemic stroke occurred in 14 patients (1.0 %/
year) and ipsilateral retinal infarction in six patients
(0.4 %/year). Myocardial infarction occurred in 20 patients
(1.5 %/year). Forty-six (13 %) patients died, 22 (6 %) from
a vascular cause. Of these 22, three patients died from
ischemic stroke, three from hemorrhagic stroke, and 16
from other vascular causes.
Table 2 and Supplementary Fig. 1 show the features of
the history that had a statistically significant association on
univariable analysis with the occurrence of the primary
outcome measure. In Fig. 1 the different patterns of visual
field loss are illustrated. On bivariable analysis, presence of
the following characteristics influenced HRs of the nine
features of TMB the most: sex, history of intermittent
claudication, history of myocardial infarction, history of
angina pectoris, and severe stenosis or occlusion of
ipsilateral ICA. After adjustment for these factors,
involvement of the peripheral but not the central part of the
visual field, constricting onset of visual field loss, down-
ward onset of loss of vision, upward resolution of loss of
vision, and occurrence of more than three attacks remained
statistically significant predictors of the outcome (Table 2).
We could not identify a feature of the history that was
consistently associated with a good outcome with respect
to the primary outcome event.
Features of TMB that predicted the secondary outcome
event on univariable analysis are summarized in Table 3.
Presence of ipsilateral ICA stenosis of 70 % or more or
occlusion had the largest influence on the crude HRs. All
risk estimates remained essentially the same after adjust-
ment for this factor (Table 3). Adjustment for carotid
endarterectomy (CEA) performed on the ipsilateral ICA
during the study did not alter the HRs for both the primary
and secondary outcome measures. Also, adjustment for the
interval between last event and CEA hardly altered the risk
of primary or secondary outcome events in the 81 patients
who underwent ipsilateral CEA during the study (data not
shown).
Discussion
This is the largest prospective series of patients with TMB
studied to date, and the only study that relates history
characteristics of TMB with clinical outcome events during
follow-up. We found that the risk of serious vascular events
in patients with TMB varies according to certain elements
of the history, independently from baseline vascular risk
factors.
Clinical features of TMB caused by emboli [2] may
resemble those caused by related diseases, such as (retinal)
Table 2 Occurrence of primary outcome (composite of vascular death, stroke, myocardial infarction, or retinal infarction) during follow-up
History characteristic Risk of primary outcome
Characteristic present n (%) Characteristic absent n (%) Crude HR with 95 % CI Adjusted HR with 95 % CIa
Completely colored VF 5/12 (42 %) 55/329 (17 %) 2.9, 1.2–7.3 2.0, 0.8–5.2
Both black and colored VF 3/6 (50 %) 57/335 (17 %) 3.4, 1.0–10.7 3.0, 0.9–10.1
Peripheral VF only 8/11 (73 %) 52/330 (16 %) 7.2, 3.4–15.2 6.5, 3.0–14.1
Altitudinal onset 16/57 (28 %) 44/284 (16 %) 2.0, 1.1–3.5 1.4, 0.8–2.5
Altitudinal resolution 15/55 (27 %) 45/286 (16 %) 1.8, 1.0–3.3 1.5, 0.8–2.7
Constricting onset 3/8 (38 %) 57/333 (17 %) 3.1, 1.0–9.8 3.5, 1.0–12.1
Downward onset 14/41 (34 %) 46/300 (15 %) 2.5, 1.4–4.6 1.9, 1.0–3.5
Upward resolution 11/33 (33 %) 49/308 (16 %) 2.4, 1.3–4.7 2.0, 1.0–4.0
Occurrence of[3 attacks 34/139 (25 %) 26/202 (13 %) 2.1, 1.2–3.5 1.7, 1.0–2.9
a Adjusted for: sex, intermittent claudication, myocardial infarction, angina pectoris, severe stenosis (C70–100 %) or occlusion of ipsilateral
ICA
VF visual field, HR hazard ratio, CI confidence interval, ICA internal carotid artery
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migraine [14–16], anterior ischemic optic neuropathy, or
ophthalmological disorders. The usual assumption is that
positive phenomena often represent migrainous attacks
[15]. In the present study, a history of migraine was indeed
associated with a good outcome (data not shown). How-
ever, since a history of migraine had little influence on the
HRs of the features of TMB on bivariable analysis, we did
not adjust for this factor.
We could not confirm the benign nature of positive
phenomena in this study, in agreement with two other
studies [10, 17]. Moreover, complete uniform coloring of
the visual field was found to be a harbinger of
cardiovascular complications in our study. Although the
association with the primary (composite) outcome was
non-significant after adjustment, completely colored visual
field remained a significant predictor of the secondary
outcome (Tables 2 and 3). This difference could be
explained by the inclusion of vascular death and myocar-
dial infarction in the primary outcome measure, which
might have diluted the association between history char-
acteristics and the occurrence of stroke and retinal
infarction.
Three history characteristics that predicted serious vas-
cular events (downward onset of loss of vision, upward
a b c d
e f g h
Fig. 1 Schematic illustrations of different visual field loss patterns.
a Completely colored visual field, b completely black visual field
with color, c involvement of peripheral visual field only, d onset of
curtain to above or below, e resolution of curtain to above or below,
f constricting onset of visual field loss, g downward onset of loss of
vision, h upward resolution of loss of vision
Table 3 Occurrence of secondary outcome (ipsilateral (non-)fatal ischemic stroke or retinal infarction) during follow-up
History characteristic Risk of secondary outcome
Characteristic present n (%) Characteristic absent n (%) Crude HR with 95 % CI Adjusted HR with 95 % CIa
Completely colored VF 3/12 (25 %) 17/329 (5 %) 5.3, 1.5–18.1 5.7, 1.6–19.6
Both black and colored VF 2/6 (33 %) 18/335 (5 %) 7.1, 1.6–30.8 6.9, 1.6–30.2
Peripheral VF only 4/11 (36 %) 16/330 (5 %) 8.3, 2.8–24.9 5.4, 1.8–16.5
Altitudinal onset 8/57 (14 %) 12/284 (4 %) 3.5, 1.4–8.6 2.5, 1.0–6.2
Altitudinal resolution 9/55 (16 %) 11/286 (4 %) 4.4, 1.8–10.7 3.8, 1.6–9.2
Downward onset 6/41 (15 %) 14/300 (5 %) 3.3, 1.3–8.7 2.6, 1.0–6.9
Upward resolution 6/33 (18 %) 14/308 (5 %) 4.3, 1.6–11.2 4.1, 1.6–10.7
a Adjusted for: severe stenosis (C70–100 %) or occlusion of ipsilateral ICA
VF visual field, HR hazard ratio, CI confidence interval, ICA internal carotid artery
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resolution of loss of vision, and occurrence of more than
three attacks) fit the classical notions about TMB best [18].
Attacks with a downward onset of visual field loss were
attributed to emboli in an earlier study [8]. Upward reso-
lution of visual field loss might occur when restriction of
blood flow to the lower part of the retina is restored last. In
other cohorts of patients with TMB or TIA in general, the
occurrence of multiple attacks has also been found to
predict recurrent vascular events [4, 6]. Involvement of the
peripheral, but not the central area of the visual field was
identified as the most powerful predictor of impending
vascular disease in our study. In this group of patients, 1
out of 11 had a history of migraine, whereas 8 patients had
an ipsilateral stenosis or occlusion of the ICA, thereby
having a higher risk of stroke. This is contrary to the results
of our previous retrospective study, in which partial
involvement of the visual field carried a significantly lower
risk of the composite vascular outcome compared with
complete blindness of one eye [19]. These conflicting
results can be explained by the lack of standardization in
the collection of data on symptoms of TMB in our previous
study, which might have induced information bias. The
fifth history characteristic that predicted vascular events in
our study—a constricting onset—was associated with
migraine in earlier studies [20, 21], and with a lower risk of
carotid atheromatous disease or a cardiac source of emboli
[8]. However, in our study, 3/7 patients reporting a con-
stricting onset had a severe stenosis or occlusion of the
ipsilateral ICA, which again raises stroke risk.
Three earlier studies distinguished subtypes of TMB
according to presumed pathophysiology [8–10]. However,
none of these studies addressed the prognostic implications
of the different patterns. It is intriguing that neither the
present study nor other studies could identify a subtype of
TMB that can confidently be characterized as ‘innocuous’,
which might have helped to explain that after ocular
attacks the overall risk of major vascular events is two to
three times lower than after hemispheral attacks [5, 22].
The incidence, prognosis and treatment of TMB in
general have been extensively studied in both community
and hospital based studies [3, 4, 6, 23–26]. In our cohort,
the overall annual incidence of cardiovascular complica-
tions was 4.4 % (95 % CI 3.4–5.7 %), which is somewhat
higher than in more recent studies [4]. As in other studies,
the incidence of retinal infarctions was low [19, 23, 25, 27].
Overall, patients with TMB associated with atheromatous
disease have a lower risk of ipsilateral stroke than patients
with cerebral TIA [5, 6]. In contrast, we found that the risk
of cardiac disease in patients with TMB was not lower than
that reported in studies on cerebral TIA [23, 28]. In the
present cohort of patients with TMB, atypical features of
the attack did not carry a higher risk of cardiac events (data
not shown), which was confirmed in a recent study [29].
The prevalence of ipsilateral ICA stenosis or occlusion in
our cohort was much higher than in a recent prospective
study of patients with TMB who were referred to a hospital
TIA-clinic with 24 h access (42.5 vs. 12.5 %) [4]. However,
patients in our cohort probably had more severe vascular
disease and atherosclerosis, reflected by a higher prevalence
of vascular risk factors and vascular comorbidity than in the
TIA-clinic study. The authors of the TIA-clinic study state in
their discussion that the prevalence of ICA stenosis among
the included TMB patients was unexpectedly low compared
with earlier studies, and argue that this lower prevalencemay
be explained by population differences [4].
Strengths of our study are that all patients were included
according to strict criteria, with exclusion of patients with
known ophthalmological disease, and that a single physi-
cian systematically interviewed all patients with a stan-
dardized questionnaire. Additionally, we adjusted for
potential confounders to ensure the associations we found
were independent from vascular risk factors. A limitation
of our study is that the cohort is hospital based, and
although it was a multicenter study, the majority of patients
were referred to university hospitals with facilities for
CEA. This is reflected in the relatively low age of the
patients. Patients who are referred to centers with CEA
facilities may more often have unequivocal TMB symp-
toms or have more vascular risk factors; hence, it is pos-
sible that we missed patients with relatively benign forms
of TMB. Therefore, the results cannot be extrapolated to all
patients with TMB. Also, recruitment took place from 1992
to 1996, which might limit generalizability of our results
due to improved medical and surgical management of
patients with TMB in the last decades. However, the higher
rate of vascular events in our cohort facilitated the study of
the relationship between history symptoms and the occur-
rence of the outcomes. Because of logistic reasons we did
not report these results soon after they were collected; the
continuing clinical problem of being confronted with a
variety of transient visual symptoms prompted us to pub-
lish our results as yet. We cannot rule out that our results
are influenced by chance, because we used many history
characteristics in the univariable analysis. Yet, symptoms
that showed a significant association with the primary and
secondary outcome measures are very similar (Tables 2
and 3), which reduces the possibility of chance. Finally, the
risk of recurrent stroke is highest within the first 2 weeks
after a TIA [30]. Therefore, the median delay of 8 weeks
between the last symptoms and entry into the study may
have induced information bias because of missing outcome
events and their associated history characteristics. On the
other hand, all patients were interviewed with a standard-
ized questionnaire, which limits the risk of recall bias.
In conclusion, the results of our study show that sub-
types of TMB carry a relatively high risk of vascular
1776 J Neurol (2016) 263:1771–1777
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complications. Careful history taking may help to assess
the prognosis of an individual patient. In particular,
involvement of the peripheral but not the central part of the
visual field, a constricting onset of visual field loss,
downward onset of loss of vision, upward resolution of loss
of vision, and the occurrence of multiple attacks of TMB
all independently carried a relatively high risk of vascular
complications. We could not identify any ‘benign’ prog-
nostic features of TMB. Therefore, the presence of unusual
or otherwise atypical symptoms should not be a reason to
withhold secondary prevention to reduce the risk of future
vascular events.
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